Abstract
Adaptation of the heart muscle in response to exercise has been extensively described. Different forms of sports may imply a different strain to the heart. In this context endurance sports are considered to induce a dynamic, isotonic workload, which is accompanied by an increase in heart rate and stroke volume and a reduction in peripheral vascular resistance.
Sudden athlete death (SAD) is a widely publicised and increasingly reported phenomenon. For many, the athlete population epitomise human physical endeavour and achievement, and their unexpected death comes with a significant emotional impact on the public.
Anabolic–androgenic steroids (AAS) are abused for enhancing muscle mass, strength growth and improving athletic performance. In recent years many observational and interventional studies have shown important adverse cardiovascular effects of AAS abuse.
Imaging with nuclear medicine with or without combined CT techniques, echocardiography and CMR are promising methods to target and image certain biomarkers in the process of cardiovascular pathology that can be used for early detection of sport- and also AAS-associated adverse effects.
This book chapter discusses the physiological background of myocardial (dys)function in athletes and established and novel nuclear molecular imaging techniques, including MRI, that may serve as potential tools for early detection of sport- and AAS-associated cardiovascular disorders and reducing cardiovascular sudden deaths in athletes.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Abbreviations
- 123I-MIBG:
-
123I-metaiodobenzylguanidine
- AS:
-
Aortic stenosis
- ACS:
-
Acute coronary syndrome
- AT1:
-
Angiotensin-1
- AAS:
-
Anabolic–androgenic steroids
- RGD:
-
Arginine–glycine–aspartate
- ARVC:
-
Arrhythmogenic right ventricular cardiomyopathy
- CO:
-
Cardiac output
- CMR:
-
Cardiovascular magnetic resonance
- CPT:
-
Cold pressure test
- CAD:
-
Coronary artery disease
- CR:
-
Coronary reserve
- CTA:
-
CT angiography
- DHEA:
-
Dehydroepiandrosterone
- ECG:
-
Electrocardiography
- FFR:
-
Fractional flow reserve
- gRE:
-
Global relative enhancement
- HCM:
-
Hypertrophic cardiomyopathy
- HRV:
-
Heart rate variability
- H/M:
-
Heart/mediastinum
- BMIPP:
-
123I-beta-methyl-iodophenylpentadecanoic acid
- IDC:
-
Idiopathic dilated cardiomyopathy
- LGE:
-
Late gadolinium enhancement
- LV:
-
Left ventricle
- LVEF:
-
Left ventricular ejection fraction
- LVH:
-
Left ventricular hypertrophy
- MBF:
-
Myocardial blood flow
- MDCT:
-
Multi-detector computed tomography
- MI:
-
Myocardial infarction
- MUGA:
-
Multigated acquisition scan
- MPI:
-
Myocardial perfusion imaging
- MPR:
-
Myocardial perfusion reserve
- PET:
-
Positron emission tomography
- RAS:
-
Renin–angiotensin system
- RPP:
-
Rate–pressure product
- RV:
-
Right ventricle
- RVEF:
-
Right ventricular ejection fraction
- SPECT:
-
Single-photon emission computed tomography
- SV:
-
Stroke volume
- SAD:
-
Sudden athlete death
- USPIO:
-
Ultra-small superparamagnetic particles of iron oxide
- VCAM-1:
-
Vascular cell adhesion molecule-1
- WR:
-
Washout rate
References
Aaron CP, Tandri H, Barr RG et al (2011) Physical activity and right ventricular structure and function. The MESA-Right Ventricle Study. Am J Respir Crit Care Med 183:396–404
Ahlgrim C, Guglin M (2009) Anabolics and cardiomyopathy in a bodybuilder: case report and literature review. J Card Fail 15:496–500
Ajayi AA, Halushka PV (2005) Castration reduces platelet thromboxane A2 receptor density and aggregability. QJM 98:349–356
Ajayi AA, Mathur R, Halushka PV (1995) Testosterone increases human platelet thromboxane A2 receptor density and aggregation responses. Circulation 91:2742–2747
Alessio AC, Santos CX, Debbas V et al (2011) Evaluation of mild hyperhomocysteinemia during the development of atherosclerosis in apolipoprotein E-deficient and normal mice. Exp Mol Pathol 90:45–50
Alves MJ, Dos Santos MR, Dias RG et al (2010) Abnormal neurovascular control in anabolic androgenic steroids users. Med Sci Sports Exerc 42:865–871
Angelilli A, Katz ES, Goldenberg RM (2005) Cardiac arrest following anaesthetic induction in a world-class bodybuilder. Acta Cardiol 60:443–444
Annovazzi A, Bonanno E, Arca M et al (2006) 99mTc-interleukin-2 scintigraphy for the in vivo imaging of vulnerable atherosclerotic plaques. Eur J Nucl Med Mol Imaging 33:117–126
Arrigan MT, Killeen RP, Dodd JD et al (2011) Imaging spectrum of sudden athlete cardiac death. Clin Radiol 66:203–223
Baggish AL, Wang F, Weiner RB et al (2008) Training-specific changes in cardiac structure and function: a prospective and longitudinal assessment of competitive athletes. J Appl Physiol 104:1121–1128
Baggish AL, Weiner RB, Kanayama G et al (2010) Long-term anabolic-androgenic steroid use is associated with left ventricular dysfunction. Circ Heart Fail 3:472–476
Bartram P, Toft J, Hanel B et al (1998) False-positive defects in technetium-99m sestamibi myocardial single-photon emission tomography in healthy athletes with left ventricular hypertrophy. Eur J Nucl Med 25:1308–1312
Basso C, Thiene G, Corrado D et al (1996) Arrhythmogenic right ventricular cardiomyopathy. Dysplasia, dystrophy, or myocarditis? Circulation 94:983–991
Basso C, Corrado D, Marcus FI et al (2009) Arrhythmogenic right ventricular cardiomyopathy. Lancet 373:1289–1300
Behrendt H, Boffin H (1977) Myocardial cell lesions caused by an anabolic hormone. Cell Tissue Res 181:423–426
Belhani D, Fanton L, Vaillant F et al (2009) Cardiac lesions induced by testosterone: protective effects of dexrazoxane and trimetazidine. Cardiovasc Toxicol 9:64–69
Bengel FM, Schwaiger M (2004) Assessment of cardiac sympathetic neuronal function using PET imaging. J Nucl Cardiol 11:603–616
Bengel FM, Higuchi T, Javadi MS et al (2009) Cardiac positron emission tomography. J Am Coll Cardiol 54:1–15
Beutel A, Bergamaschi CT, Campos RR (2005) Effects of chronic anabolic steroid treatment on tonic and reflex cardiovascular control in male rats. J Steroid Biochem Mol Biol 93:43–48
Bissoli NS, Medeiros AR, Santos MC et al (2009) Long-term treatment with supraphysiological doses of nandrolone decanoate reduces the sensitivity of Bezold-Jarisch reflex control of heart rate and blood pressure. Pharmacol Res 59:379–384
Bjarnason NH, Bjarnason K, Haarbo J et al (1997) Tibolone: influence on markers of cardiovascular disease. J Clin Endocrinol Metab 82:1752–1756
Briley-Saebo KC, Cho YS, Tsimikas S (2011) Imaging of oxidation-specific epitopes in atherosclerosis and macrophage-rich vulnerable plaques. Curr Cardiovasc Imaging Rep 4:4–16
Buyukdereli G, Kanadasi M, Kibar M (2005) Washout rates of Tc-99m tetrofosmin in asymmetric septal hypertrophy. Ann Nucl Med 19:29–33
Calkins H (2008) Arrhythmogenic right ventricular dysplasia. Trans Am Clin Climatol Assoc 119:273–286
Cecchi F, Olivotto I, Gistri R et al (2003) Coronary microvascular dysfunction and prognosis in hypertrophic cardiomyopathy. N Engl J Med 349:1027–1035
Chen W, Bural GG, Torigian DA et al (2009) Emerging role of FDG-PET/CT in assessing atherosclerosis in large arteries. Eur J Nucl Med Mol Imaging 36:144–151
Choudhury L, Guzzetti S, Lefroy DC et al (1996a) Myocardial beta adrenoceptors and left ventricular function in hypertrophic cardiomyopathy. Heart 75:50–54
Choudhury L, Rosen SD, Lefroy DC et al (1996b) Myocardial beta adrenoceptor density in primary and secondary left ventricular hypertrophy. Eur Heart J 17:1703–1709
Cooper LT Jr (2009) Myocarditis. N Engl J Med 360:1526–1538
Corrado D, Basso C, Schiavon M et al (1998) Screening for hypertrophic cardiomyopathy in young athletes. N Engl J Med 339:364–369
Corrado D, Pelliccia A, Bjornstad HH et al (2005) Cardiovascular pre-participation screening of young competitive athletes for prevention of sudden death: proposal for a common European protocol. Consensus Statement of the Study Group of Sport Cardiology of the Working Group of Cardiac Rehabilitation and Exercise Physiology and the Working Group of Myocardial and Pericardial Diseases of the European Society of Cardiology. Eur Heart J 26:516–524
Corrado D, Basso C, Pavei A et al (2006) Trends in sudden cardiovascular death in young competitive athletes after implementation of a preparticipation screening program. JAMA 296:1593–1601
Danad I, Raijmakers PG, Appelman YE et al (2012) Quantitative relationship between coronary artery calcium score and hyperemic myocardial blood flow as assessed by hybrid 15O-water PET/CT imaging in patients evaluated for coronary artery disease. J Nucl Cardiol 19:256–264
Danias PG, Ahlberg AW, Clark BA III et al (1998) Combined assessment of myocardial perfusion and left ventricular function with exercise technetium-99m sestamibi gated single-photon emission computed tomography can differentiate between ischemic and nonischemic dilated cardiomyopathy. Am J Cardiol 82:1253–1258
de Jong RM, Willemsen AT, Slart RH et al (2005) Myocardial beta-adrenoceptor downregulation in idiopathic dilated cardiomyopathy measured in vivo with PET using the new radioligand (S)-[11C]CGP12388. Eur J Nucl Med Mol Imaging 32:443–447
de Vries J, DeJongste MJ, Jessurun GA et al (2006) Myocardial perfusion quantification in patients suspected of cardiac syndrome X with positive and negative exercise testing: a [13N]ammonia positron emission tomography study. Nucl Med Commun 27:791–794
Dec GW, Palacios I, Yasuda T et al (1990) Antimyosin antibody cardiac imaging: its role in the diagnosis of myocarditis. J Am Coll Cardiol 16:97–104
Dilsizian V, Bonow RO, Epstein SE et al (1993) Myocardial ischemia detected by thallium scintigraphy is frequently related to cardiac arrest and syncope in young patients with hypertrophic cardiomyopathy. J Am Coll Cardiol 22:796–804
Drezner JA, Ackerman MJ, Anderson J et al (2013) Electrocardiographic interpretation in athletes: the ‘Seattle criteria’. Br J Sports Med 47:122–124
Ector J, Ganame J, van der Merwe N et al (2007) Reduced right ventricular ejection fraction in endurance athletes presenting with ventricular arrhythmias: a quantitative angiographic assessment. Eur Heart J 28:345–353
Fanton L, Belhani D, Vaillant F et al (2009) Heart lesions associated with anabolic steroid abuse: comparison of post-mortem findings in athletes and norethandrolone-induced lesions in rabbits. Exp Toxicol Pathol 61:317–323
Ferrer M, Encabo A, Marin J et al (1994) Chronic treatment with the anabolic steroid, nandrolone, inhibits vasodilator responses in rabbit aorta. Eur J Pharmacol 252:233–241
Fineschi V, Riezzo I, Centini F et al (2007) Sudden cardiac death during anabolic steroid abuse: morphologic and toxicologic findings in two fatal cases of bodybuilders. Int J Legal Med 121:48–53
Fisker Hag AM, Pedersen SF, Kjaer A (2008) Gene expression of LOX-1, VCAM-1, and ICAM-1 in pre-atherosclerotic mice. Biochem Biophys Res Commun 377:689–693
Flotats A, Carrio I, Agostini D et al (2010) Proposal for standardization of 123I-metaiodobenzylguanidine (MIBG) cardiac sympathetic imaging by the EANM Cardiovascular Committee and the European Council of Nuclear Cardiology. Eur J Nucl Med Mol Imaging 37:1802–1812
Fontana K, Oliveira HC, Leonardo MB et al (2008) Adverse effect of the anabolic-androgenic steroid mesterolone on cardiac remodelling and lipoprotein profile is attenuated by aerobicz exercise training. Int J Exp Pathol 89:358–366
Freed LA, Levy D, Levine RA et al (1999) Prevalence and clinical outcome of mitral-valve prolapse. N Engl J Med 341:1–7
Friedrich MG, Sechtem U, Schulz-Menger J et al (2009) Cardiovascular magnetic resonance in myocarditis: a JACC White Paper. J Am Coll Cardiol 53:1475–1487
Gawaz M, Langer H, May AE (2005) Platelets in inflammation and atherogenesis. J Clin Invest 115:3378–3384
Germano G, Kiat H, Kavanagh PB et al (1995) Automatic quantification of ejection fraction from gated myocardial perfusion SPECT. J Nucl Med 36:2138–2147
Ghadri JR, Fiechter M, Veraguth K et al (2012) Coronary calcium score as an adjunct to nuclear myocardial perfusion imaging for risk stratification before noncardiac surgery. J Nucl Med 53:1081–1086
Gimelli A, Landi P, Marraccini P et al (2008) Left ventricular ejection fraction measurements: accuracy and prognostic implications in a large population of patients with known or suspected ischemic heart disease. Int J Cardiovasc Imaging 24:793–801
Goldberger JJ, Cain ME, Hohnloser SH et al (2008) American Heart Association/American College of Cardiology Foundation/Heart Rhythm Society Scientific Statement on Noninvasive Risk Stratification Techniques for Identifying Patients at Risk for Sudden Cardiac Death. A scientific statement from the American Heart Association Council on Clinical Cardiology Committee on Electrocardiography and Arrhythmias and Council on Epidemiology and Prevention. J Am Coll Cardiol 52:1179–1199
Golestani R, Slart RH, Dullaart RP et al (2012) Adverse cardiovascular effects of anabolic steroids: pathophysiology imaging. Eur J Clin Invest 42:795–803
Graham MR, Grace FM, Boobier W et al (2006) Homocysteine induced cardiovascular events: a consequence of long term anabolic-androgenic steroid (AAS) abuse. Br J Sports Med 40:644–648
Grigioni F, Enriquez-Sarano M, Ling LH et al (1999) Sudden death in mitral regurgitation due to flail leaflet. J Am Coll Cardiol 34:2078–2085
Gurtner HP, Walser P, Fassler B (1975) Normal values for pulmonary hemodynamics at rest and during exercise in man. Prog Respir Res 9:295–315
Hartgens F, Kuipers H (2004) Effects of androgenic-anabolic steroids in athletes. Sports Med 34:513–554
Hartgens F, Rietjens G, Keizer HA et al (2004) Effects of androgenic-anabolic steroids on apolipoproteins and lipoprotein (a). Br J Sports Med 38:253–259
Hayek E, Gring CN, Griffin BP (2005) Mitral valve prolapse. Lancet 365:507–518
Hendel RC, Cerqueira M, Douglas PS et al (2010) A multicenter assessment of the use of single-photon emission computed tomography myocardial perfusion imaging with appropriateness criteria. J Am Coll Cardiol 55:156–162
Ibrahim el-SH (2012) Imaging sequences in cardiovascular magnetic resonance: current role, evolving applications, and technical challenges. Int J Cardiovasc Imaging 28:2027–2047
James OG, Christensen JD, Wong TZ et al (2011) Utility of FDG PET/CT in inflammatory cardiovascular disease. Radiographics 31:1271–1286
John AS, Dill T, Brandt RR et al (2003) Magnetic resonance to assess the aortic valve area in aortic stenosis: how does it compare to current diagnostic standards? J Am Coll Cardiol 42:519–526
Kajander S, Joutsiniemi E, Saraste M et al (2010) Cardiac positron emission tomography/computed tomography imaging accurately detects anatomically and functionally significant coronary artery disease. Circulation 122:603–613
Kapur A, Latus KA, Davies G et al (2002) A comparison of three radionuclide myocardial perfusion tracers in clinical practice: the ROBUST study. Eur J Nucl Med Mol Imaging 29:1608–1616
Kaufmann PA, Di Carli MF (2009) Hybrid SPECT/CT and PET/CT imaging: the next step in noninvasive cardiac imaging. Semin Nucl Med 39:341–347
Kelesidis I, Travin MI (2012) Use of cardiac radionuclide imaging to identify patients at risk for arrhythmic sudden cardiac death. J Nucl Cardiol 19:142–152
Koh AS, Flores JL, Keng FY et al (2011) Evaluation of the American College of Cardiology Foundation/American Society of Nuclear Cardiology appropriateness criteria for SPECT myocardial perfusion imaging in an Asian tertiary cardiac center. J Nucl Cardiol 18:324–330
La Gerche A, Heidbuchel H, Burns AT et al (2011) Disproportionate exercise load and remodeling of the athlete’s right ventricle. Med Sci Sports Exerc 43:974–981
La Gerche A, Burns AT, Mooney DJ et al (2012) Exercise-induced right ventricular dysfunction and structural remodelling in endurance athletes. Eur Heart J 33:998–1006
Laaksonen MS, Kalliokoski KK, Luotolahti M et al (2007) Myocardial perfusion during exercise in endurance-trained and untrained humans. Am J Physiol Regul Integr Comp Physiol 293:R837–R843
Laitinen I, Saraste A, Weidl E et al (2009) Evaluation of alphavbeta3 integrin-targeted positron emission tomography tracer 18F-galacto-RGD for imaging of vascular inflammation in atherosclerotic mice. Circ Cardiovasc Imaging 2:331–338
Lane HA, Grace F, Smith JC et al (2006) Impaired vasoreactivity in bodybuilders using androgenic anabolic steroids. Eur J Clin Invest 36:483–488
Lefroy DC, de Silva R, Choudhury L et al (1993) Diffuse reduction of myocardial beta-adrenoceptors in hypertrophic cardiomyopathy: a study with positron emission tomography. J Am Coll Cardiol 22:1653–1660
Lerch H, Bartenstein P, Wichter T et al (1993) Sympathetic innervation of the left ventricle is impaired in arrhythmogenic right ventricular disease. Eur J Nucl Med 20:207–212
Lotze U, Kober A, Kaepplinger S et al (1999) Cardiac sympathetic activity as measured by myocardial 123-I-metaiodobenzylguanidine uptake and heart rate variability in idiopathic dilated cardiomyopathy. Am J Cardiol 83:1548–1551
Lotze U, Kaepplinger S, Kober A et al (2001) Recovery of the cardiac adrenergic nervous system after long-term beta-blocker therapy in idiopathic dilated cardiomyopathy: assessment by increase in myocardial 123I-metaiodobenzylguanidine uptake. J Nucl Med 42:49–54
Luijkx T, Velthuis BK, Backx FJ et al (2013) Anabolic androgenic steroid use is associated with ventricular dysfunction on cardiac MRI in strength trained athletes. Int J Cardiol 167:664–668
Magnani JW, Dec GW (2006) Myocarditis: current trends in diagnosis and treatment. Circulation 113:876–890
Majmudar MD, Nahrendorf M (2012) Cardiovascular molecular imaging: the road ahead. J Nucl Med 53:673–676
Margari ZJ, Anastasiou-Nana MI, Terrovitis J et al (2003) Indium-111 monoclonal antimyosin cardiac scintigraphy in suspected acute myocarditis: evolution and diagnostic impact. Int J Cardiol 90:239–245
Maron BJ (1986) Structural features of the athlete heart as defined by echocardiography. J Am Coll Cardiol 7:190–203
Maron BJ (1998) Cardiovascular risks to young persons on the athletic field. Ann Intern Med 129:379–386
Maron BJ, Roberts WC, McAllister HA et al (1980) Sudden death in young athletes. Circulation 62:218–229
Maron BJ, Pelliccia A, Spirito P (1995) Cardiac disease in young trained athletes. Insights into methods for distinguishing athlete’s heart from structural heart disease, with particular emphasis on hypertrophic cardiomyopathy. Circulation 91:1596–1601
Maron BJ, McKenna WJ, Danielson GK et al (2003) American College of Cardiology/European Society of Cardiology clinical expert consensus document on hypertrophic cardiomyopathy. A report of the American College of Cardiology Foundation Task Force on Clinical Expert Consensus Documents and the European Society of Cardiology Committee for Practice Guidelines. J Am Coll Cardiol 42:1687–1713
Maron BJ, Thompson PD, Ackerman MJ et al (2007) Recommendations and considerations related to preparticipation screening for cardiovascular abnormalities in competitive athletes: 2007 update: a scientific statement from the American Heart Association Council on Nutrition, Physical Activity, and Metabolism: endorsed by the American College of Cardiology Foundation. Circulation 115:1643–455
Maron BJ, Doerer JJ, Haas TS et al (2009) Sudden deaths in young competitive athletes: analysis of 1866 deaths in the United States, 1980–2006. Circulation 119:1085–1092
Matsuda K, Ruff A, Morinelli TA et al (1994) Testosterone increases thromboxane A2 receptor density and responsiveness in rat aortas and platelets. Am J Physiol 267:H887–H893
Matsuo S, Nakamura Y, Takahashi M et al (2001) Cardiac sympathetic dysfunction in an athlete’s heart detected by 123I-metaiodobenzylguanidine scintigraphy. Jpn Circ J 65:371–374
McCrohon JA, Moon JC, Prasad SK et al (2003) Differentiation of heart failure related to dilated cardiomyopathy and coronary artery disease using gadolinium-enhanced cardiovascular magnetic resonance. Circulation 108:54–59
Medei E, Marocolo M, Rodrigues DC et al (2010) Chronic treatment with anabolic steroids induces ventricular repolarization disturbances: cellular, ionic and molecular mechanism. J Mol Cell Cardiol 49:165–175
Miyagawa M, Anton M, Wagner B et al (2005) Non-invasive imaging of cardiac transgene expression with PET: comparison of the human sodium/iodide symporter gene and HSV1-tk as the reporter gene. Eur J Nucl Med Mol Imaging 32:1108–1114
Mohiaddin RH, Amanuma M, Kilner PJ et al (1991) MR phase-shift velocity mapping of mitral and pulmonary venous flow. J Comput Assist Tomogr 15:237–243
Mudd JO, Kass DA (2008) Tackling heart failure in the twenty-first century. Nature 451:919–928
Nagueh SF, Mahmarian JJ (2006) Noninvasive cardiac imaging in patients with hypertrophic cardiomyopathy. J Am Coll Cardiol 48:2410–2422
Nahrendorf M, Jaffer FA, Kelly KA et al (2006) Noninvasive vascular cell adhesion molecule-1 imaging identifies inflammatory activation of cells in atherosclerosis. Circulation 114:1504–1511
Nahrendorf M, Keliher E, Panizzi P et al (2009) 18F-4V for PET/CT imaging of VCAM-1 expression in atherosclerosis. JACC Cardiovasc Imaging 2:1213–1222
Nava A, Bauce B, Basso C et al (2000) Clinical profile and long-term follow-up of 37 families with arrhythmogenic right ventricular cardiomyopathy. J Am Coll Cardiol 36:2226–2233
Ong PJ, Patrizi G, Chong WC et al (2000) Testosterone enhances flow-mediated brachial artery reactivity in men with coronary artery disease. Am J Cardiol 85:269–272
Pelliccia A, Maron BJ, Spataro A et al (1991) The upper limit of physiologic cardiac hypertrophy in highly trained elite athletes. N Engl J Med 324:295–301
Pelliccia A, Spataro A, Caselli G et al (1993) Absence of left ventricular wall thickening in athletes engaged in intense power training. Am J Cardiol 72:1048–1054
Pelliccia A, Culasso F, Di Paolo FM et al (1999) Physiologic left ventricular cavity dilatation in elite athletes. Ann Intern Med 130:23–31
Pereira-Junior PP, Chaves EA, Costa-E-Sousa RH et al (2006) Cardiac autonomic dysfunction in rats chronically treated with anabolic steroid. Eur J Appl Physiol 96:487–494
Petersen SE, Selvanayagam JB, Francis JM et al (2005) Differentiation of athlete’s heart from pathological forms of cardiac hypertrophy by means of geometric indices derived from cardiovascular magnetic resonance. J Cardiovasc Magn Reson 7:551–558
Pinamonti B, Alberti E, Cigalotto A et al (1988) Echocardiographic findings in myocarditis. Am J Cardiol 62:285–291
Prakken NH, Velthuis BK, Teske AJ et al (2010) Cardiac MRI reference values for athletes and nonathletes corrected for body surface area, training hours/week and sex. Eur J Cardiovasc Prev Rehabil 17:198–203
Prakken NH, Cramer MJ, Teske AJ et al (2011) The effect of age in the cardiac MRI evaluation of the athlete’s heart. Int J Cardiol 149:68–73
Prior DL, La Gerche A (2012) The athlete’s heart. Heart 98:947–955
Rispler S, Aronson D, Abadi S et al (2011) Integrated SPECT/CT for assessment of haemodynamically significant coronary artery lesions in patients with acute coronary syndrome. Eur J Nucl Med Mol Imaging 38:1917–1925
Rocha FL, Carmo EC, Roque FR et al (2007) Anabolic steroids induce cardiac renin-angiotensin system and impair the beneficial effects of aerobic training in rats. Am J Physiol Heart Circ Physiol 293:H3575–H3583
Rybczynska AA, Elsinga PH, Sijbesma JW et al (2009) Steroid hormones affect binding of the sigma ligand 11C-SA4503 in tumour cells and tumour-bearing rats. Eur J Nucl Med Mol Imaging 36:1167–1175
Sader MA, Griffiths KA, Skilton MR et al (2003) Physiological testosterone replacement and arterial endothelial function in men. Clin Endocrinol (Oxf) 59:62–67
Schafers M, Dutka D, Rhodes CG et al (1998) Myocardial presynaptic and postsynaptic autonomic dysfunction in hypertrophic cardiomyopathy. Circ Res 82:57–62
Schattke S, Wagner M, Hattasch R et al (2012) Single beat 3D echocardiography for the assessment of right ventricular dimension and function after endurance exercise: intraindividual comparison with magnetic resonance imaging. Cardiovasc Ultrasound 10:6
Schindler TH, Facta AD, Prior JO et al (2006) PET-measured heterogeneity in longitudinal myocardial blood flow in response to sympathetic and pharmacologic stress as a non-invasive probe of epicardial vasomotor dysfunction. Eur J Nucl Med Mol Imaging 33:1140–1149
Sen-Chowdhry S, Prasad SK, Syrris P et al (2006) Cardiovascular magnetic resonance in arrhythmogenic right ventricular cardiomyopathy revisited: comparison with task force criteria and genotype. J Am Coll Cardiol 48:2132–2140
Skouri HN, Dec GW, Friedrich MG et al (2006) Noninvasive imaging in myocarditis. J Am Coll Cardiol 48:2085–2093
Slart RH, Bax JJ, de Jong RM et al (2004) Comparison of gated PET with MRI for evaluation of left ventricular function in patients with coronary artery disease. J Nucl Med 45:176–182
Slart RH, Bax JJ, De Boer J et al (2005) Comparison of (99m)Tc-sestamibi/(18)FDG DISA SPECT with PET for the detection of viability in patients with coronary artery disease and left ventricular dysfunction. Eur J Nucl Med Mol Imaging 32:972–979
Slart RH, Bax JJ, van Veldhuisen DJ (2006) Prediction of functional recovery after revascularisation in patients with chronic ischaemic left ventricular dysfunction: head-to-head comparison (99m)Tc-sestamibi/(18)FDG DISA SPECT and (13)N-ammonia/(18)F-FDG PET. Eur J Nucl Med Mol Imaging 33:716–723
Slart RH, Zeebregts CJ, Hillege HL et al (2011) Myocardial perfusion reserve after a PET-driven revascularization procedure: a strong prognostic factor. J Nucl Med 52:873–879
Sorensen J, Valind S, Andersson LG (2010) Simultaneous quantification of myocardial perfusion, oxidative metabolism, cardiac efficiency and pump function at rest and during supine bicycle exercise using 1–11C-acetate PET–a pilot study. Clin Physiol Funct Imaging 30:279–284
Spirito P, Pelliccia A, Proschan MA et al (1994) Morphology of the “athlete’s heart” assessed by echocardiography in 947 elite athletes representing 27 sports. Am J Cardiol 74:802–806
Stacy MR, Maxfield MW, Sinusas AJ (2012) Targeted molecular imaging of angiogenesis in PET and SPECT: a review. Yale J Biol Med 85:75–86
Stergiopoulos K, Brennan JJ, Mathews R et al (2008) Anabolic steroids, acute myocardial infarction and polycythemia: a case report and review of the literature. Vasc Health Risk Manag 4:1475–1480
Tabas I, Williams KJ, Boren J (2007) Subendothelial lipoprotein retention as the initiating process in atherosclerosis: update and therapeutic implications. Circulation 116:1832–1844
Terai H, Shimizu M, Ino H et al (2003a) Cardiac sympathetic nerve activity in patients with hypertrophic cardiomyopathy with malignant ventricular tachyarrhythmias. J Nucl Cardiol 10:304–310
Terai H, Shimizu M, Ino H et al (2003b) Changes in cardiac sympathetic nerve innervation and activity in pathophysiologic transition from typical to end-stage hypertrophic cardiomyopathy. J Nucl Med 44:1612–1617
Thiene G, Basso C (2001) Arrhythmogenic right ventricular cardiomyopathy: an update. Cardiovasc Pathol 10:109–117
Tio RA, Dabeshlim A, Siebelink HM et al (2009a) Comparison between the prognostic value of left ventricular function and myocardial perfusion reserve in patients with ischemic heart disease. J Nucl Med 50:214–219
Tio RA, Slart RH, de Boer RA et al (2009b) Reduced regional myocardial perfusion reserve is associated with impaired contractile performance in idiopathic dilated cardiomyopathy. Neth Heart J 17:470–474
Toraa M, Pouillard F, Merlet P et al (1999) Cardiac hypertrophy and coronary reserve in endurance athletes. Can J Appl Physiol 24:87–95
Towbin JA, Bowles NE (2002) The failing heart. Nature 415:227–233
Urhausen A, Albers T, Kindermann W (2004) Are the cardiac effects of anabolic steroid abuse in strength athletes reversible? Heart 90:496–501
van Amsterdam J, Opperhuizen A, Hartgens F (2010) Adverse health effects of anabolic-androgenic steroids. Regul Toxicol Pharmacol 57:117–123
van den Borne SW, Isobe S, Verjans JW et al (2008) Molecular imaging of interstitial alterations in remodeling myocardium after myocardial infarction. J Am Coll Cardiol 52:2017–2028
van der Vleuten PA, Slart RHJA, Tio RA et al (2005) The feasibility of repeated left ventricular ejection fraction analysis with sequential single-dose radionuclide ventriculography. Nucl Med Commun 26:711–715
Vanhoenacker PK, Heijenbrok-Kal MH, Van HR et al (2007) Diagnostic performance of multidetector CT angiography for assessment of coronary artery disease: meta-analysis. Radiology 244:419–428
Verjans JW, Lovhaug D, Narula N et al (2008) Noninvasive imaging of angiotensin receptors after myocardial infarction. JACC Cardiovasc Imaging 1:354–362
Vriens PW, Blankenberg FG, Stoot JH et al (1998) The use of technetium Tc 99m annexin V for in vivo imaging of apoptosis during cardiac allograft rejection. J Thorac Cardiovasc Surg 116:844–853
Whitsel EA, Boyko EJ, Matsumoto AM et al (2001) Intramuscular testosterone esters and plasma lipids in hypogonadal men: a meta-analysis. Am J Med 111:261–269
Wilson M, O’Hanlon R, Prasad S et al (2011) Diverse patterns of myocardial fibrosis in lifelong, veteran endurance athletes. J Appl Physiol 110:1622–1626
Wu FC, von Eckardstein A (2003) Androgens and coronary artery disease. Endocr Rev 24:183–217
Zaugg M, Jamali NZ, Lucchinetti E et al (2001) Anabolic-androgenic steroids induce apoptotic cell death in adult rat ventricular myocytes. J Cell Physiol 187:90–95
Zhang X, Xiong Z, Wu Y et al (2006) Quantitative PET imaging of tumor integrin alphavbeta3 expression with 18F-FRGD2. J Nucl Med 47:113–121
Zhao C, Shuke N, Okizaki A et al (2003) Comparison of myocardial fatty acid metabolism with left ventricular function and perfusion in cardiomyopathies: by 123I-BMIPP SPECT and 99mTc-tetrofosmin electrocardiographically gated SPECT. Ann Nucl Med 17:541–548
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2015 Springer-Verlag Berlin Heidelberg
About this chapter
Cite this chapter
Slart, R.H.J.A., Tio, R.A., Nieuwland, W. (2015). The Heart as a Special Muscle in Athletes and Anabolic–Androgenic Steroids (Ab)use. In: Glaudemans, A., Dierckx, R., Gielen, J., Zwerver, J. (eds) Nuclear Medicine and Radiologic Imaging in Sports Injuries. Springer, Berlin, Heidelberg. https://doi.org/10.1007/978-3-662-46491-5_44
Download citation
DOI: https://doi.org/10.1007/978-3-662-46491-5_44
Publisher Name: Springer, Berlin, Heidelberg
Print ISBN: 978-3-662-46490-8
Online ISBN: 978-3-662-46491-5
eBook Packages: MedicineMedicine (R0)